Skip to main content
    C

    Compass Therapeutics Inc. (CMPX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.66
    -0.11 (-14.51%)

    Market Cap: $139.35M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Compass Therapeutics Inc. (CMPX) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Compass Therapeutics (CMPX) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, Compass Therapeutics reported EPS of -$0.15, below the -$0.12 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    41%(9/22)
    Avg Surprise
    -5.21%

    Upcoming Estimates

    Reports Mar 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.15
    Range-$0.17 - -$0.13
    17 analysts
    Revenue Consensus
    N/A
    RangeN/A
    16 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.13
    Range-$0.16 - -$0.11
    6 analysts
    EPS Revisions
    3
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.14+7.1%
    60d ago-$0.15+11.2%
    30d ago-$0.130.0%
    7d ago-$0.130.0%
    Current-$0.13
    Revenue Consensus
    N/A
    RangeN/A
    9 analysts

    Next Report

    CMPX has an expected report date of Mar 3, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, CMPX beat 9, missed 11 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 200.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.15-$0.12-$0.15 - -$0.10-25.00%MissN/A112 up, 0 downNov 9, 2026
    Jun 30, 2026-$0.13-$0.10-$0.15 - -$0.09-30.00%MissN/A120 up, 3 downAug 6, 2026
    Mar 31, 2026-$0.10-$0.10-$0.15 - -$0.060.00%In lineN/A111 up, 4 downMay 5, 2026
    Dec 31, 2025-$0.09-$0.10-$0.14 - -$0.02+5.66%BeatN/A136 up, 1 downMar 5, 2026
    Sep 30, 2025-$0.08-$0.14-$0.17 - -$0.09+42.86%BeatN/A8N/ANov 5, 2025
    Jun 30, 2025-$0.14-$0.12-$0.13 - -$0.09-16.67%MissN/A71 up, 0 downAug 11, 2025
    Mar 31, 2025-$0.12-$0.11-$0.15 - -$0.05-9.09%MissN/A90 up, 2 downMay 8, 2025
    Dec 31, 2024-$0.11-$0.10-$0.14 - -$0.06-10.00%MissN/A91 up, 0 downFeb 27, 2025
    Sep 30, 2024-$0.08-$0.11-$0.14 - -$0.10+27.27%BeatN/A60 up, 0 downNov 12, 2024
    Jun 30, 2024-$0.10-$0.09-$0.11 - -$0.08-11.11%MissN/A60 up, 0 downAug 12, 2024
    Mar 31, 2024-$0.08-$0.11-$0.12 - -$0.10+27.27%BeatN/A70 up, 0 downMay 13, 2024
    Dec 31, 2023-$0.11-$0.09-$0.11 - -$0.08-22.22%MissN/A70 up, 0 downMar 21, 2024
    Sep 30, 2023-$0.08-$0.11-$0.12 - -$0.09+27.27%BeatN/A70 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.09-$0.08-$0.10 - -$0.07-12.50%MissN/A70 up, 0 downAug 3, 2023
    Mar 31, 2023-$0.06-$0.11-$0.12 - -$0.10+45.45%BeatN/A70 up, 0 downMay 4, 2023
    Dec 31, 2022-$0.10-$0.11-$0.13 - -$0.10+9.09%BeatN/A80 up, 0 downMar 15, 2023
    Sep 30, 2022-$0.12-$0.12-$0.16 - -$0.090.00%In lineN/A60 up, 0 downNov 9, 2022
    Jun 30, 2022-$0.08-$0.07-$0.14 - -$0.06-14.29%MissN/A70 up, 0 downAug 1, 2022
    Mar 31, 2022-$0.07-$0.13-$0.15 - -$0.07+46.15%BeatN/A60 up, 0 downMay 9, 2022
    Dec 31, 2021-$0.21-$0.07-$0.08 - -$0.07-200.00%MissN/A70 up, 0 downMar 21, 2022
    Sep 30, 2021-$0.10-$0.11-$0.15 - -$0.10+9.09%BeatN/A2N/ANov 12, 2021
    Jun 30, 2021-$1.07-$1.03N/A-3.88%MissN/AN/AN/AAug 16, 2021
    Mar 31, 2021-$0.14N/AN/AN/AN/AN/AN/AN/AApr 30, 2021
    Dec 31, 2020-$0.16N/AN/AN/AN/AN/AN/AN/AMar 5, 2021
    Sep 30, 2020-$0.18N/AN/AN/AN/AN/AN/AN/ANov 9, 2020
    Jun 30, 2020-$0.18N/AN/AN/AN/AN/AN/AN/AAug 13, 2020
    Mar 31, 2020-$0.41N/AN/AN/AN/AN/AN/AN/AJun 8, 2020
    Dec 31, 2019-$0.90N/AN/AN/AN/AN/AN/AN/AFeb 13, 2020
    Sep 30, 2019-$0.95N/AN/AN/AN/AN/AN/AN/ANov 13, 2019
    Jun 30, 2019-$1.27N/AN/AN/AN/AN/AN/AN/AJul 1, 2019
    Mar 31, 2019-$1.33N/AN/AN/AN/AN/AN/AN/AJun 30, 2019
    Last 31 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.43, after -$0.37 the year before. It was -$4.45 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.43N/A
    Dec 31, 2024-$0.37N/A
    Dec 31, 2023-$0.34N/A
    Dec 31, 2022-$0.37N/A
    Dec 31, 2021-$1.52N/A
    Dec 31, 2020-$0.93N/A
    Dec 31, 2019-$4.45N/A

    Frequently Asked Questions About CMPX

    When is Compass Therapeutics's next earnings date?

    Compass Therapeutics's next earnings report is expected for Mar 3, 2027.

    Did CMPX beat earnings estimates last quarter?

    No. Compass Therapeutics reported EPS of -$0.15 for the quarter ended Sep 30, 2026, below the -$0.12 estimate by 25.00%.

    What EPS do analysts expect from CMPX next quarter?

    The consensus EPS estimate for Compass Therapeutics for the quarter ending Dec 31, 2026 is -$0.15 from 17 analysts, with estimates from -$0.17 to -$0.13.

    How often does CMPX beat earnings estimates?

    Compass Therapeutics beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -5.28%.